Related Experiment Video
Updated: Jan 6, 2026

Statistical Modelling of Cortical Connectivity Using Non-invasive Electroencephalograms
Published on: November 1, 2019
A comparison of arm-based and contrast-based models for network meta-analysis
Ian R White1, Rebecca M Turner1, Amalia Karahalios2
1MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
Network meta-analysis (NMA) models, arm-based (AB) and contrast-based (CB), have key differences. Both AB and CB models are suitable for NMA, but random study intercepts require strong justification.
Area of Science:
- Biostatistics
- Medical Informatics
Background:
- Network meta-analysis (NMA) models, specifically arm-based (AB) and contrast-based (CB) approaches, present debated differences in application.
- Existing models include the Lu-Ades (2006) CB model, the Hong et al. (2016) AB model, and intermediate variations.
Purpose of the Study:
- To compare the Lu-Ades CB model, the Hong et al. AB model, and two intermediate models for NMA.
- To elucidate the primary differences stemming from fixed versus random study intercepts.
Main Methods:
- Comparative analysis using hypothetical and real datasets.
- Examination of four key differences related to study intercepts and model assumptions.
Main Results:
- Fixed study intercepts utilize only within-study data, while random intercepts incorporate between-study data, potentially introducing bias.
- Random study intercepts facilitate broader estimands but require external data for optimal risk derivation; fixed intercepts are equally effective with external data.
- The Hong model permits relating treatment effects to study intercepts, unlike the Lu-Ades model.
- The Hong model's relaxed missing data assumption (missing at random arms) does not appear to mitigate bias.
Conclusions:
- Both AB and CB models are appropriate for NMA.
- The use of random study intercepts in NMA models necessitates a robust rationale, such as linking treatment effects to study intercepts.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Comparing the Survival Analysis of Two or More Groups
Bioequivalence Data: Statistical Interpretation
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Multiple Comparison Tests
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...

